Egységes gyógyszerészeti adagolási forma, amely tartalmaz Tenofovir DF-et, Emtricitabint, Efavirenzt és egy szurfaktánst

• 收藏
• 分享

专利权人:

Bristol-Myers Squibb & Gilead Sciences; LLC

发明人:

DAHL, Terrence, C.,Hussain, Munir, A.,Lipper, Robert, A.,Jerzewski, Robert, L.,MENNING, Mark, M.,OLIYAI, Reza,YANG, Taiyin

申请号：

HUE11167101

公开号：

HUE025089T2

申请日:

2006.06.13

申请国别(地区):

HU

年份:

2016

代理人:

摘要：

In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir DF are provided as a multicomponent unitary oral dosage form, component 1 comprising tenovofir DF (and, optionally, emtricitabine) and component 2 comprising efavirenz, wherein components 1 and 2 are in a stabilizing configuration. In preferred embodiments component 1 is made by dry granulation. In another embodiment a composition comprising tenovofir DF and a surfactant is claimed.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/